Solvonis Therapeutics plc (LON:SVNS)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 0.1000
+0.0075 (8.11%)
Nov 5, 2026, 4:35 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 6.81 million as of November 5, 2026. It is the 42,324th most valuable company in the world and the 952nd biggest in the United Kingdom. Its market cap has decreased by 66.67% in one year.
Market Cap
6.81M
Enterprise Value
6.22M
Revenue
n/a
Global Rank
Country Rank
#952 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 6.81M, a decrease of -70.45%. That is a compound annual growth rate of -22.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 6.81M | -67.74% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 13.44M |
| SkinBioTherapeutics | 13.02M |
| Genflow Biosciences | 10.31M |
| Thalia Therapeutics | 9.78M |
| Aptamer Group | 9.37M |
| Palatin Technologies | 7.26M |
| Fusion Antibodies | 7.26M |
| CRISM Therapeutics | 6.73M |